VMD

VMD (VMD) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 12,500 VND, little changed on the session, giving a market capitalization of 223.9 billion VND.

On valuation, VMD trades at a price-to-earnings ratio of 8.2 and a price-to-book of 0.5. That is a discount to the Health Care sector average P/E of 18.9. Return on equity of 6.5% points to modest profitability relative to the company's equity base, below the sector average of 11.3%. Trailing earnings per share stand at 1,778 VND.

Aveluro tracks 10 news items mentioning VMD, where recent coverage skews negative (90% of articles). The most recent catalyst was a dividend announcement event — "Vietnam Dividend Week Oct 26-30: NTC Pays 60% Cash, TCB 50% Stock". Aveluro's composite model rates VMD 6.9/10 (Bullish), blending news sentiment, price momentum, and fundamentals.

Comparable names in the Health Care sector include AGP, AMP and AMV.

Recent developments around VMD include 5 notable classified events. On Oct 26, 2026, a dividend announcement was reported: Nam Tân Uyên Industrial Park (NTC, HOSE) tops Vietnam's October 26-30 dividend calendar with a 60% cash payout, VND 6,000 per share, on a record date of October 26, 2026. On Oct 05, 2026, a market event was reported: HOSE trimmed its Q4/2026 margin-ineligible list to 65 tickers from 73, but the roster still spans 25 warning-status names, eight with negative first-half 2026 parent profit including MHC and STK, and audit-qualified filings at AAT, KLB, GIL and VTB. On Sep 11, 2026, a market event was reported: VMD of Y Dược phẩm Vimedimex will move from controlled to restricted trading on HOSE from September 16, 2026 under Decision 702/QĐ-SGDHCM, after continued breaches of information disclosure rules. On Aug 07, 2026, a market event was reported: HOSE has expanded its margin-ineligible list to 57 securities, including Vietnam Airlines (HVN), Duc Giang Chemicals (DGC), and newly listed DMX. On Jun 12, 2026, a leadership change was reported: Vimedimex Pharmaceutical (VMD) faces a leadership shake-up as a board member and three supervisory board members resign ahead of the 2026 Annual General Meeting scheduled for June 12.

The overall tone of recent coverage is negative, with 4 of 5 events carrying bearish sentiment.